Aptus Endosystems Lands $15,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Aptus Endosystems
  • Mailing Address
    777 N. Pastoria Avenue Sunnyvale, CA 94085-2918
  • Company Description
    Aptus Endosystems is a privately held, well-funded, emerging medical device company that is engaged in the development of next generation minimally invasive endograft devices, delivery systems and fixation technology for the treatment of Abdominal Aortic Aneurysm – the 13th leading cause of death in the United States and the 10th leading cause of death in men over the age of 55.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to advance clinical and commercial development in Europe and continue the U.S. regulatory processes related to the Aptus EndoStapling System as both a stand-alone product and as part of the Aptus Endovascular AAA Repair System. The company is also pursuing development for a thoracic aortic aneurysm (TAA) repair system and further innovation of its abdominal aortic aneurysm (AAA) repair system.
  • M&A Terms
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    Longitude Capital Management

Trending on Xconomy